![François Durvye](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
François Durvye
Directeur/Membre du Conseil chez
QUANTUM GENOMICS
Profil
François Durvye is the founder of Alfeor SAS, founded in 2023.
Mr. Durvye is currently Director at Quantum Genomics SA and Independent Director at Recherche Exploitation Produits SAS. Mr. Durvye was Chief Executive Officer at Otium Management SAS from 2022 to 2026.
Postes actifs de François Durvye
| Sociétés | Poste | Début |
|---|---|---|
| QUANTUM GENOMICS | Directeur/Membre du Conseil | - |
Recherche Exploitation Produits SAS
 Recherche Exploitation Produits SAS Chemicals: Major DiversifiedProcess Industries Engages in the designing, developing, formulating and marketing chemical products | Directeur/Membre du Conseil | - |
Anciens postes connus de François Durvye
| Sociétés | Poste | Fin |
|---|---|---|
Otium Capital SARL
 Otium Capital SARL Investment ManagersFinance Otium Capital invests in companies located in France. The firm focuses on industrial, leisure, real estate, healthcare, consumer and technology. It participates in seed, early, later, growth and LBO transactions with an investment size of EUR 0.002 - 0.2 million. The firm acquires majority and minority interests. | Directeur Général | 01/03/2026 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Quantum Genomics SA
 Quantum Genomics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for cardiovascular diseases | Health Technology |
Recherche Exploitation Produits SAS
Recherche Exploitation Produits SAS Chemicals: Major DiversifiedProcess Industries Engages in the designing, developing, formulating and marketing chemical products | Process Industries |
Otium Capital SARL
Otium Capital SARL Investment ManagersFinance Otium Capital invests in companies located in France. The firm focuses on industrial, leisure, real estate, healthcare, consumer and technology. It participates in seed, early, later, growth and LBO transactions with an investment size of EUR 0.002 - 0.2 million. The firm acquires majority and minority interests. | Finance |
